Rule 8.1- Bionostics plc

RNS Number:8166M
Bionostics PLC
30 January 2008


                                    FORM 8.1
          DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES
                  FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
                 (Rules 8.1(a) and (b)(i) of the Takeover Code)

1. KEY INFORMATION

Name of person dealing (Note 1)        Kelly Winn
Company dealt in                       Bionostics plc
Class of relevant security to which    Ordinary Shares of 25 Pence each
the dealings being disclosed relate
(Note 2)
Date of dealing                        29 January 2008


2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)

                                                          Long                       Short
                                                Number            (%)       Number            (%)
(1) Relevant securities                         236,250           0.47%
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total                                           236,250           0.47%


(b) Interests and short positions in relevant securities of the company, other
    than the class dealt in (Note 3)

Class of relevant security:                              Long                       Short
                                                Number             (%)      Number            (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

(c) Rights to subscribe (Note 3)

Class of relevant security:          Details


3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale                  Number of securities                    Price per unit (Note 5)
Purchase                       10,566 ordinary shares of 25p each      25.5p
                               

(b) Derivatives transactions (other than options)

Product name,     Long/short (Note 6)  Number of securities (Note 7)  Price per unit (Note 5)
e.g. CFD                               


(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,    Writing,      Number of        Exercise  Type, e.g.  Expiry   Option money
e.g. call        selling,      securities to    price     American,   date     paid/received
option           purchasing,   which the option           European             per unit
                 varying       relates (Note 7)           etc.                 (Note 5)
                 etc.


(ii) Exercising

Product name, e.g. call option     Number of securities      Exercise price per unit (Note 5)
                                                      

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8)      Details                  Price per unit (if applicable) (Note 5)
                                                             
Pruchase of shares relating
to exercise of options              See 3(a) above           25.5p


4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting rights of any relevant securities under any
option referred to on this form or relating to the voting rights or future acquisition or
disposal of any relevant securities to which any derivative referred to on this form is
referenced. If none, this should be stated.


Is a Supplemental Form 8 attached? (Note 9)                   NO

Date of disclosure                                            29 January 2008

Contact name                                                  Kelly Winn

Telephone number                                              001 (978) 772-7070

Name of offeree/offeror with which associated                 Bionostics plc

Specify category and nature of associate status (Note 10)     Company Secretary



Notes

The Notes on Form 8.1 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk






















                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
DCCPUUWWGUPRGMB
Biofocus (LSE:BIO)
過去株価チャート
から 5 2024 まで 6 2024